Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7336)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 18, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nakamoto S, Kanda T, Shirasawa H, Yokosuka O. Antiviral therapies for chronic hepatitis C virus infection with cirrhosis. World J Hepatol 2015; 7(8): 1133-1141 [PMID: 26052402 DOI: 10.4254/wjh.v7.i8.1133] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i8/1133.htm |
| Number | Citing Articles |
| 1 |
Chisa Kondo, Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hiroshi Abe, Toru Asano, Kai Yoshizawa, Tomomi Okubo, Yoshimichi Chuganji, Yoshio Aizawa, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri. Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease. Hepatology Research 2017; 47(11): 1165 doi: 10.1111/hepr.12879
|
| 2 |
Kathleen B. Schwarz, Hongxia Li. Zakim and Boyer's Hepatology. 2018; : 1015 doi: 10.1016/B978-0-323-37591-7.00065-3
|
| 3 |
Shoshanna May, Feza Kurmoo, Mariesa Iliffe, Joicy David, Ayushi Patel, Martin Wiselka, Iain Stephenson, Toby Delahooke, Florence Y Lai, Simon Dustan, Julian W Tang. Comparative hepatitis C genotype 1–3 viral load kinetics in response to directly-acting antiviral therapy. Journal of Infection 2020; 80(5): 578 doi: 10.1016/j.jinf.2020.01.011
|
| 4 |
María Carolina Martínez-Bohorquez, Martha Carnalla, Norberto Chávez-Tapia, Tonatiuh Barrientos-Gutiérrez. Hepatitis C mortality trends in Mexico from 2001 to 2017. Annals of Hepatology 2023; 28(3): 101083 doi: 10.1016/j.aohep.2023.101083
|
| 5 |
Elena Enache, Anca Sin, Ligia Bancu, Christophe Ramière, Olivier Diaz, Patrice André, Liviu Enache. Duplex High-Resolution Melting Assay for the Simultaneous Genotyping of IL28B rs12979860 and PNPLA3 rs738409 Polymorphisms in Chronic Hepatitis C Patients. International Journal of Molecular Sciences 2015; 16(9): 22223 doi: 10.3390/ijms160922223
|
| 6 |
Jim Young, Nina Weis, Harald Hofer, William Irving, Ola Weiland, Emiliano Giostra, Juan Manuel Pascasio, Lluis Castells, Martin Prieto, Roelien Postema, Cinira Lefevre, David Evans, Heiner C. Bucher, Jose Luis Calleja. The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-016-2106-x
|
| 7 |
P Guntipalli, R Pakala, S Kumari Gara, F Ahmed, A Bhatnagar, M.-K. Endaya Coronel, A.A. Razzack, A.G. Solimando, A Thompson, K Andrews, G Enebong Nya, S Ahmed, R Ranaldo, R Cozzolongo, E Shahini. Worldwide prevalence, genotype distribution and management of hepatitis C. Acta Gastro Enterologica Belgica 2021; 84(4): 633 doi: 10.51821/84.4.015
|
| 8 |
Wissal Liman, Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Didier Villemin, Rachid Daoud, Driss Cherqaoui, Achraf El Allali. Monte Carlo Method and GA-MLR-Based QSAR Modeling of NS5A Inhibitors against the Hepatitis C Virus. Molecules 2022; 27(9): 2729 doi: 10.3390/molecules27092729
|
| 9 |
M. Megan Chacon, Austin J. Adams, Cale A. Kassel, Nicholas W. Markin. High-Risk and Hepatitis C–Positive Organ Donors: Current Practice in Heart, Lung, and Liver Transplantation. Journal of Cardiothoracic and Vascular Anesthesia 2020; 34(9): 2492 doi: 10.1053/j.jvca.2019.12.012
|
| 10 |
Rohan Janardhan Meshram, Gunderao Hanumantrao Kathwate, Rajesh Nivarti Gacche. Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections. Archives of Virology 2022; 167(3): 717 doi: 10.1007/s00705-022-05375-0
|
| 11 |
Ryota Masuzaki, Tatsuo Kanda, Haruhiko Yoshida, Naoya Kato, Masao Omata. Hepatocellular Carcinoma. 2016; : 261 doi: 10.1007/978-3-319-34214-6_17
|
| 12 |
Jordan J. Feld, David E. Bernstein, Ziad Younes, Hans Van Vlierberghe, Lois Larsen, Fernando Tatsch, Peter Ferenci. Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin. Liver International 2018; 38(9): 1571 doi: 10.1111/liv.13708
|
| 13 |
Masahiro Shinoda, Hirotoshi Ebinuma, Osamu Itano, Yoshiyuki Yamagishi, Hideaki Obara, Minoru Kitago, Nobuhiro Nakamoto, Taizo Hibi, Hiroshi Yagi, Yuta Abe, Kentaro Matsubara, Po‐sung Chu, Yuko Wakayama, Nobuhito Taniki, Akihiro Yamaguchi, Ryusuke Amemiya, Rei Miyake, Takamasa Mizota, Takanori Kanai, Yuko Kitagawa. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatology Research 2016; 46(11): 1118 doi: 10.1111/hepr.12666
|
| 14 |
Lourdes Maria Pinheiro Borzacov, Larissa Deadame de Figueiredo Nicolete, Luan Felipo Botelho Souza, Alcione Oliveira dos Santos, Deusilene Souza Vieira, Juan Miguel Villalobos Salcedo. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir. International Journal of Infectious Diseases 2016; 46: 82 doi: 10.1016/j.ijid.2016.03.017
|
| 15 |
O. V. Masalova, E. I. Lesnova, K. Yu. Permyakova, E. I. Samokhvalov, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Effect of Hepatitis C virus proteins on the production of proinflammatory and profibrotic cytokines in Huh7.5 human hepatoma cells. Molecular Biology 2016; 50(3): 422 doi: 10.1134/S0026893316020163
|
| 16 |
Arthi Venkatesan, Febin Prabhu Dass J.. Review on chemogenomic approaches towards hepatitis C viral targets. Journal of Cellular Biochemistry 2019; 120(8): 12167 doi: 10.1002/jcb.28581
|
| 17 |
Bénédicte Vanwalscappel, Sylvie Rato, Mayte Perez-Olmeda, Francisco Díez Fuertes, Nicoletta Casartelli, José Alcami, Fabrizio Mammano. Genetic and phenotypic analyses of sequential vpu alleles from HIV-infected IFN-treated patients. Virology 2017; 500: 247 doi: 10.1016/j.virol.2016.10.028
|
| 18 |
Arturo Panduro, Sonia Roman. Need of righteous attitudes towards eradication of hepatitis C virus infection in Latin America. World Journal of Gastroenterology 2016; 22(22): 5137-5142 doi: 10.3748/wjg.v22.i22.5137
|
| 19 |
Yan A. Ivanenkov, Vladimir A. Aladinskiy, Nikolay A. Bushkov, Andrey A. Ayginin, Alexander G. Majouga, Alexandre V. Ivachtchenko. Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015). Expert Opinion on Therapeutic Patents 2017; 27(4): 401 doi: 10.1080/13543776.2017.1272573
|
| 20 |
Min Gu Kang, Min Jung Kang, Eunhee Ji, Bong Kyu Yoo. Meta-analysis of the Efficacy and Safety of Grazoprevir and Elbasvir for the Treatment of Hepatitis C Virus Infection. Korean Journal of Clinical Pharmacy 2017; 27(3): 150 doi: 10.24304/kjcp.2017.27.3.150
|
| 21 |
Ayodeji A. Agbowuro, Wilhelmina M. Huston, Allan B. Gamble, Joel D. A. Tyndall. Proteases and protease inhibitors in infectious diseases. Medicinal Research Reviews 2018; 38(4): 1295 doi: 10.1002/med.21475
|
| 22 |
Kohei Kaneko, Tsutomu Ishihara, Lisa Du Toit. Development of liver-specific ribavirin-loaded nanoparticles with reduced cytotoxicity. Cogent Medicine 2017; 4(1): 1418133 doi: 10.1080/2331205X.2017.1418133
|